Ask My Investor AI
Public company · NYSEPublished company research
FMC

Identity verified against SEC EDGAR filing 0000037785-26-000041; registered as FMC CORP, CIK 0000037785.

FMC Corporation

FMC Corporation is mapped to the Food-system volatility control theme as Crop protection pure-play: patented insecticides/herbicides addressing pest and weed pressure, including resistance-management chemistry. Medium exposure with strengthening product-level evidence: Q1 2026 revenue was $759m (-4% y/y) with adjusted EBITDA of $72m and a $281m GAAP net loss, so the financial base is stressed; but the rimisoxafen pipeline directly monetizes a volatility bottleneck — resistant-weed pressure — evidenced by Corteva's $200m prepurchase payment (2026-06-16) and the first global regulatory submission to EPA (2026-07-08). Balance-sheet repair (Tessenderlo's $400m for ~20% ownership, 2026-06-30; $252m India divestiture) reduces financial risk to the pipeline. Theme materiality is stated separately and, where not independently verified, is marked accordingly.

Ask follow-up research
Reviewed company research · researched 2026-07-22 · not an individual investment recommendation
Listing
public
Ticker
FMC
Exchange
NYSE
HQ
—
Currency
USD
SEC CIK
0000037785
Investment case

How this company captures the theme economics

Competitive position

Medium exposure with strengthening product-level evidence: Q1 2026 revenue was $759m (-4% y/y) with adjusted EBITDA of $72m and a $281m GAAP net loss, so the financial base is stressed; but the rimisoxafen pipeline directly monetizes a volatility bottleneck — resistant-weed pressure — evidenced by Corteva's $200m prepurchase payment (2026-06-16) and the first global regulatory submission to EPA (2026-07-08). Balance-sheet repair (Tessenderlo's $400m for ~20% ownership, 2026-06-30; $252m India divestiture) reduces financial risk to the pipeline. Company-specific competitive positioning is assessed at the theme level and awaits deeper primary research.

Scarce assets

Scarce assets in this value chain include water access and water-efficient application capacity (irrigation installed base, dealer networks), proprietary germplasm, trait pipelines and regulatory approvals (multi-year, capital-intensive to replicate; resistance-management chemistry such as fmc's rimisoxafen), potash and nitrogen production capacity concentrated in few jurisdictions; logistics chokepoints (strait of hormuz event of q2 2026) can reprice nutrients abruptly.

Products, segments, and customers

FMC Corporation operates in Food-system volatility control. Segment- and product-level detail is pending company-specific research.

Theme capture

Medium exposure with strengthening product-level evidence: Q1 2026 revenue was $759m (-4% y/y) with adjusted EBITDA of $72m and a $281m GAAP net loss, so the financial base is stressed; but the rimisoxafen pipeline directly monetizes a volatility bottleneck — resistant-weed pressure — evidenced by Corteva's $200m prepurchase payment (2026-06-16) and the first global regulatory submission to EPA (2026-07-08). Balance-sheet repair (Tessenderlo's $400m for ~20% ownership, 2026-06-30; $252m India divestiture) reduces financial risk to the pipeline.

Conditions

What must be true

  1. Q2 2026 results 2026-07-29: channel inventory status and guidance integrity; track EPA review milestones for rimisoxafen and terms of the Corteva partnership.
  2. The exposure described for FMC Corporation must be confirmed as financially material in official filings.

Identifiable catalysts

  • Forthcoming quarterly and annual issuer filings
  • Theme-level catalysts detailed in the Food-system volatility control brief
Theme materiality

1 mapped theme

Exposure statements are evidence-qualified. Materiality is only claimed where disclosure supports it.

Crop protection pure-play: patented insecticides/herbicides addressing pest and weed pressure, including resistance-management chemistry

Food-system volatility control

Medium exposure with strengthening product-level evidence: Q1 2026 revenue was $759m (-4% y/y) with adjusted EBITDA of $72m and a $281m GAAP net loss, so the financial base is stressed; but the rimisoxafen pipeline directly monetizes a volatility bottleneck — resistant-weed pressure — evidenced by Corteva's $200m prepurchase payment (2026-06-16) and the first global regulatory submission to EPA (2026-07-08). Balance-sheet repair (Tessenderlo's $400m for ~20% ownership, 2026-06-30; $252m India divestiture) reduces financial risk to the pipeline.

Evidence
Fetched StockTitan news list for FMC (accessed 2026-07-22) covering the 2026-04-29 Q1 release, reaffirmed FY2026 guidance ($3.60-3.80bn revenue ex-India, $670-730m EBITDA), and the dated pipeline/ownership events. Direct IR pages did not render for automated fetch.
Materiality
disclosed — FMC is a single-segment crop-protection company, so disclosed company financials are the theme-relevant financials; pipeline monetization value remains estimated/uncertain pending regulatory outcomes.
Financial evidence

Official SEC filing evidence

Reference period: FY2025.

  • Operating income$-1.63 billion
    FY2025[1]
  • EBITDA$-1.45 billion
    FY2025[1]
  • Diluted EPS$-17.88
    FY2025[1]
  • Total debt$4.07 billion
    FY2025 year-end[1]
  • Net debt / EBITDA-2.40x
    FY2025 year-end[1]
  • Return on invested capital-0.3%
    FY2025[1]
  • Cash and equivalents$585 million
    FY2025 year-end[1]

Limitation: Filing evidence establishes scale, profitability, cash generation, and leverage. Market-derived valuation is withheld until a licensed market-data feed is connected, and theme materiality is stated separately.

Risks

Material risks and break conditions

Material risks

  • Benign-supply cycle: June 2026 evidence (record-track wheat/rice output, US corn stocks +14% y/y, FFPI stable) is closer to the thesis-break scenario than to the shock scenario; a second benign year would further delay resilience capex
  • Farm-economics adoption constraint is partially active now: Deere PPA -14%, Lindsay NA irrigation -11%, Valmont agriculture -15.8% all attribute weakness to farm income and credit (Brazil), not to lack of product relevance

Thesis-break conditions

  • Benign weather break: FAO Food Price Index holds within roughly 120-135 for eight-plus consecutive quarters while global cereal stocks set successive records and US crop insurance loss ratios run below the long-run 0.85 average — volatility premium fails to materialize
  • Input abundance break: FAO fertilizer basket sustains below ~$400/tonne for 12+ months with no disruption events (vs $489/t in Sept 2025), and nitrogen/potash producers report volume growth without price leverage
Investability conclusion

Where the evidence lands

Identity and filing financials are established; theme materiality is stated per the mapped theme assessment. This is a filing-backed research profile with deeper company-specific research pending, and is not a personalized recommendation.

Next diligence

  1. Q2 2026 results 2026-07-29: channel inventory status and guidance integrity; track EPA review milestones for rimisoxafen and terms of the Corteva partnership.
Source ledger

Identity and evidence sources

Identity was verified against official issuer, filing, exchange, or regulator sources where available.

  1. FMC CORP FY2025 Form 10-KSEC EDGAR · primary · published 2026-02-27 · accessed 2026-07-22